Sintia Teichman

Sintia Teichman is a Principal at Sixty Degree Capital, a global investment firm focused on the technology and healthcare sectors. She originally joined the organization as an Investment Analyst in May 2021 before advancing to her current leadership position. In her current role, Teichman specializes in life sciences investments, directing venture capital toward emerging companies across the biotechnology, biopharmaceutical, and healthcare technology industries. Prior to entering the professional venture capital industry, she earned a PhD and conducted extensive academic research at the University of Toronto. Her scientific work primarily explored complex topics in immunology, stem cell biology, and regenerative medicine, with a specific emphasis on autoimmune diseases such as colitis and type 1 diabetes. Today, Teichman leverages her deep academic expertise to evaluate and financially support early-stage medical innovations within the broader global healthcare ecosystem.